|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 254, Issue 5 E588-E594, Copyright © 1988 by American Physiological Society
ARTICLES |
H. Lochs, P. E. Williams, E. L. Morse, N. N. Abumrad and S. A. Adibi
Clinical Nutrition Unit, Montefiore Hospital, Pittsburgh, Pennsylvania 15213.
Oligopeptides may enter the bloodstream from endogenous and exogenous sources. Using an organ-balance technique in conscious dogs, we investigated the role of individual organs in removal of two model oligopeptides (glycylleucine and glycylglycine) from plasma under steady-state conditions. Despite an identical infusion rate, arterial concentration of glycylglycine was twofold greater than that of glycylleucine. This appeared to be a result of greater fractional extraction of glycylleucine than glycylglycine by organs. Although all of the organs examined participated in removal of dipeptides from plasma, their roles varied. Liver, kidney, muscle, and gut accounted for the disappearance of 25, 24, 12, and 10% of the infused amount of glycylleucine, respectively. With glycylglycine as the substrate, disappearance across kidney accounted for 37% of the infused amount, whereas muscle, liver, and gut accounted for 18, 15, and 11%, respectively. Finally, we investigated glycine and leucine balances across organs with infusion of these amino acids in free and dipeptide forms. Glycine and leucine balances were uniquely more positive across muscle during the infusion of glycylleucine than the corresponding amino acid mixture. The possible mechanisms included release of products of glycylleucine hydrolysis by all organs except muscle. We conclude that molecular structure influences the organ extraction of dipeptides; if extraction, particularly by the liver, is not sufficiently rapid, kidney assumes a greater role than other organs in dipeptide removal from plasma.
This article has been cited by other articles:
![]() |
G. Garibotto, R. Russo, A. Sofia, M. Vettore, L. Dertenois, C. Robaudo, G. Deferrari, M. Zanetti, and P. Tessari Role of blood cells in leucine kinetics across the human kidney Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1430 - F1437. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Fischman, H. Hsu, E. A. Carter, Y. M. Yu, R. G. Tompkins, J. L. Guerrero, V. R. Young, and N. M. Alpert Regional measurement of canine skeletal muscle blood flow by positron emission tomography with H215O J Appl Physiol, April 1, 2002; 92(4): 1709 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fürst Old and New Substrates in Clinical Nutrition J. Nutr., May 1, 1998; 128(5): 789 - 796. [Full Text] |
||||
![]() |
Y. Pan, P. K. Bender, R. M. Akers, and K. E. Webb Jr. One or More Serum Factors Promote Peptide Utilization in Cultured Animal Cells J. Nutr., April 1, 1998; 128(4): 744 - 750. [Abstract] [Full Text] |
||||
![]() |
Y. Pan and K. E. Webb Jr. Peptide-Bound Methionine as Methionine Sources for Protein Accretion and Cell Proliferation in Primary Cultures of Ovine Skeletal Muscle J. Nutr., February 1, 1998; 128(2): 251 - 256. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |